BriaCell Therapeutics Corp. (TSX:BCT)
Canada
· Delayed Price · Currency is CAD 4.080
-0.140 (-3.32%)
Jun 27, 2025, 3:55 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-1.68M CAD
Market Cap
26.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sienna Senior Living | 12,263 |
| Green Thumb Industries | 4,800 |
| dentalcorp Holdings | 10,200 |
| Extendicare | 23,000 |
| WELL Health Technologies | 1,507 |
| Cronos Group | 459 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
BriaCell Therapeutics News
- 3 days ago - BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 23 days ago - BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewsWire
- 25 days ago - BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 4 weeks ago - BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - GlobeNewsWire
- 5 weeks ago - BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 5 weeks ago - BriaCell CEO Letter to Shareholders - GlobeNewsWire
- 2 months ago - BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified - GlobeNewsWire
- 2 months ago - BriaCell Therapeutics closes $13.8M public offering - Seeking Alpha